Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Genetic modification via nucleic acid introduction refers to the process of altering an organism’s genetic material by physically introducing DNA or RNA into cells. This can involve methods such as recombinant DNA, gene editing (e.g., CRISPR-Cas9), viral vector delivery, or plasmid transfection[1][2][5]. The process is widely used in research, agriculture, and medicine to create genetically modified organisms, correct genetic diseases (gene therapy), produce therapeutic proteins, or study gene function. It does not define a unique molecular entity, but rather a family of biotechnological methods.
Introduction of foreign or modified nucleic acids to change cellular function or phenotype Repair, removal, or addition of genetic material via techniques like CRISPR-Cas9, plasmid transformation, viral transduction, or gene targeting
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Genetic modification via nucleic acid introduction.